A polymeric micelle MRI contrast agent with changeable relaxivity

Journal of Controlled Release

Volumn 114, Issue 3, 2006, Pages 325-333

  Nakamura, Emiko ^a   Makino, Kimiko ^a   Okano, Teruo ^b   Yamamoto, Tatsuhiro ^c   Yokoyama, Masayuki ^c  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Contrast agent; MRI; Polymeric micelle; Relaxivity; Targeting

Indexed keywords

BLOCK COPOLYMERS; CHEMICAL BONDS; DISSOCIATION; MAGNETIC RESONANCE IMAGING; PROTONS; RELAXATION PROCESSES;

CONTRAST AGENTS; POLYMERIC MICELLES; RELAXIVITY;

MICELLES;

ALLYLAMINE DERIVATIVE; ANION; ASPARTIC ACID DERIVATIVE; CATION; COPOLYMER; GADOLINIUM; GADOLINIUM PENTETATE; MACROGOL DERIVATIVE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; POLY(ETHYLENE GLYCOL) B POLY(ASPARTIC ACID); POLYMER; PROTAMINE; PROTON; UNCLASSIFIED DRUG; WATER;

ARTICLE; CONJUGATION; CONTRAST; DISSOCIATION; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; FEASIBILITY STUDY; MICELLE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERIZATION; PRIORITY JOURNAL; SOLID TUMOR;

CONTRAST MEDIA; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MICELLES; NEOPLASMS; POLYMERS;

EID: 33748609093     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.05.030     Document Type: Article

References (42)

1. Bogdanov Jr. A., and Weissleder R. In vivo imaging of gene delivery and expression. Trends Biotech. 8 (2002) S11-S18 (Suppl.)
2. Aime S., Botta M., Fasano M., and Terreno E. Lanthanide(III) chelates for NMR biomedical applications. Chem. Soc. Rev. 27 (1998) 19-29
3. Desser T.S., Rubin D.L., Muller H.H., Qing F., Khodor S., Zanazzi G., Young S.W., Ladd D.L., Wellons J.A., Kellar K.E., Toner J.L., and Snow R.A. Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular. J. Magn. Reson. Imaging 4 (1994) 467-472
4. Doble D.M.J., Botta M., Wang J., Aime S., Barge A., and Raymond K.N. Optimization of the relaxivity of MRI contrast agents: effect of poly(ethylene glycol) chains on the water-exchange rates of GdIII complexes. J. Am. Chem. Soc. 123 (2001) 10758-10759
5. 254: a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI. Bioconjug. Chem. 12 (2001) 587-593
6. Kobayashi H., Kawamoto S., Jo S.K., Bryant Jr. H.L., Brechbiel M.W., and Star R.A. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjug. Chem. 14 (2003) 388-394
7. Langereis S., Lussanet Q.G., Genderen M.H.P., Backes W.H., and Meijer E.W. Multivalent contrast agents based on Gadolinium-diethylenetriaminepentaacetic acid-terminated poly(propylene imine) dendrimers for magnetic resonance imaging. Macromolecules 37 (2004) 3084-3091
8. Venditto V.J., Aida C., and Brechbiel M.W. PANAM dendrimer based macromolecules as improved contrast agents. Mol. Pharmacol. 2 (2005) 302-311
9. 3+-diethylenetriaminepentaacetic acid and dextran: 1. Synthesis, characterization, and paramagnetic properties. Bioconjug. Chem. 8 (1997) 605-610
10. Corot C., Schaffer M., Beaute S., Bourrinet P., Zehaf S., Benize V., Sabatou M., and Meyer D. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. Acta Radiol. 38 Supplement 412 (1997) 91-99
11. Helbich T.H., Gossman A., Mareski P.A., Raduchel B., Roberts T.P.L., Shames D.M., Muhler M., Turetschek K., and Brasch R.G. A new polysaccharide macromolecular contrast against for MR imaging: biodistribution and imaging characteristics. J. Magn. Reson. Imaging 11 (2000) 694-701
12. Lebduskova P., Kotek J., Hermann P., Elst L.V., Muller R.N., Lukes I., and Peters J.A. A gadlinium(III) complex of a carboxylic-phosphorus acid derivative of dietylenetriamine covalently bound to inulin, a potential macromolecular MRI contrast agent. Bioconjug. Chem. 15 (2004) 881-889
13. Mohs A.M., Wang X., Goodrich K.C., Zong Y., Parker D.L., and Lu Z.-R. PEG-g-poly(GdDTPA-co-l-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging. Bioconjug. Chem. 15 (2004) 1424-1430
14. Bogdanov Jr. A., Wright S.C., Marecos E.M., Bogdanova A., Martin C., Petherick P., and Weissleder R. A long-circulating co-polymer in "passive targeting" to solid tumors. J. Drug Target. 4 (1997) 321-330
15. Kobayashi H., Sato N., Saga T., Nakamoto Y., Ishimori T., Toyama S., Togashi K., Konishi J., and Brechbiel M.W. Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity. Eur. J. Nucl. Med. 27 (2000) 1334-1339
16. Konda S.D., Aref M., Wang S., Brechbiel M., and Wiener E.C. Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magn. Reson. Mat. Phys. Biol. Med. 12 (2001) 104-113
17. Lokling K.E., Fossheim S.L., Klaveness J., and Skurtveit R. Biodistribution of pH-responsive liposomes for MRI and a novel approach to improve the pH-responsiveness. J. Control. Release 98 (2004) 87-95
18. Mikawa M., Miwa N., Brautigam M., Akaike T., and Maruyama A. Gd3+-loaded polyion complex for pH depiction with magnetic resonance imaging. J. Biomed. Mater. Res. 49 (2000) 390-395
19. Louie A.Y., Huber M.M., Ahrens E.T., Rothbacher U., Moats R., Jacobs R.E., Fraser S.E., and Meade T.J. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18 (2000) 321-325
20. Yokoyama M. Polymeric micelles for the targeting of hydrophobic drugs. In: Kwon G.S. (Ed). Polymeric Drug Delivery Systems (2005), Taylor & Francis, Boca Raton 533-576
21. Yokoyama M. Drug targeting with polymeric micelle drug carriers. In: Yui N. (Ed). Supramolecular Design for Biological Applications (2002), CRC Press, Boca Raton 245-267
22. Lavasanifar A., Samuel J., and Kwon G.S. Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv. Drug Deliv. Rev. 54 (2002) 169-190
23. Kabanov A.V., and Alakhov V.Y. In: Alexandridis P., and Lindman B. (Eds). Amphiphilic Block Copolymers: Self Assembly and Applications (1997), Elsevier, Netherlands 1-31
24. Yokoyama M., Yamada N., Okano T., Sakurai Y., Kataoka K., and Inoue S. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 51 (1991) 3229-3236
25. Kwon G.S., Suwa S., Yokoyama M., Okano T., Sakurai Y., and Kataoka K. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J. Control. Release 29 (1994) 17-23
26. Yokoyama M., Okano T., Sakurai Y., Fukushima S., Okamoto K., and Kataoka K. Selective delivery of adiramycin to a solid tumor using a polymeric micelle carrier system. J. Drug Target. 7 (1999) 171-186
27. Matsumura Y., and Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46 (1986) 6387-6392
28. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41 (2001) 189-207
29. Nakanishi T., Fukushima S., Okamoto K., Suzuki M., Matsumura Y., Yokoyama M., Okano T., Sakurai Y., and Kataoka K. Development of the polymer micelle carrier system for doxorubicin. J. Control. Release 74 (2001) 295-302
30. Hamaguchi T., Matsumura Y., Suzuki M., Shimizu K., Goda R., Nakamura I., Nakatomi I., Yokoyama M., Kataoka K., and Kakizoe T. NK105, a Paclitaxel-incorporating micellar nanoparticle formulation, can extend the therapeutic window of the drug. Br. J. Cancer 92 (2005) 1240-1246
31. Earls J.P., and Bluemke D.A. New MR imaging contrast agents. Magn. Reson. Imaging Clin. N. Am. 7 (1999) 255-273
32. Cravan P., Ellison J.J., McMurry T.J., and Lauffer R.B. Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99 (1999) 2293-2352
33. Yokoyama M., Kwon G.S., Okano T., Sakurai Y., Seto T., and Kataoka K. Preparation of micelle-forming polymer-drug conjugates. Bioconjug. Chem. 3 (1992) 295-301
34. Gross E., and Meienhofer J. The formation of peptide bonds: a general survey. In: Gross E., and Meienhofer J. (Eds). The Peptides Analysis, Synthesis, Biology vol. 1 (1980), Academic Press, New York 65-109
35. Saudek V., Pivcova H., and Drobnik J. NMR study of poly(aspartic acid): II. α- and β-peptide bonds in poly(aspartic acid) prepared by common methods. Biopolymers 20 (1981) 1615-1623
36. Pathak A.P., Bimi B., Glunde K., Ackerstaff E., Artemov D., and Bhujwalla Z.M. Molecular and functional imaging of cancer: advances in MRI and MRS. Methods Enzymol. 386 (2004) 3-60
37. Lu Z.R., Wang X., Parker D.L., Goodrich K.C., and Buswell H.R. Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging. Bioconjug. Chem. 14 (2003) 715-719
38. Mathur-de-Vre R., and Lemort M. Invited review: biophysical properties and clinical applications of magnetic resonance imaging contrast agents. Br. J. Radiol. 68 (1995) 225-247
39. Ladd D.L., Hollister R., Peng X., Wei D., Wu G., Delecki D., Snow R.A., Toner J., Kelar K., Eck J., Desai V.C., Raymond G., Kinter L.B., Desser T.S., and Rubin D.M. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties. Bioconjug. Chem. 10 (1999) 361-370
40. Schuhmann-Giampieri G., Schmitt-Willich H., Frenzel T., Press W.-R., and Weinmann H.-J. In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest. Radiol. 26 (1991) 969-974
41. Wikstrom M.G., Moseley M., White D., Dupon J.W., Winkelhake J., Kopplin J., and Brasch R.C. Contrast-enhanced MRI of tumors comparison of Gd-DTPA and a macromolecular agent. Invest. Radiol. 24 (1989) 609-615
42. Accardo A., Tesauro D., Roscigno P., Gianolio E., Paduano L.D., Errico G., Pedone C., and Morelli G. Physicochemical properties pf mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI. J. Am. Chem. Soc. 126 (2004) 3097-3107